Está disponible para descarga el artículo Effect of Continuous Glucose Monitoring on Glycemic Control in Adults with Type 1 Diabetes Using Insulin Injections.

 

Autores:

RoyW. Beck, MD, PhD; Tonya Riddlesworth, PhD; Katrina Ruedy, MSPH; Andrew Ahmann, MD;

Richard Bergenstal, MD; Stacie Haller, RD, LD, CDE; Craig Kollman, PhD; Davida Kruger, MSN, APN-BC;

Janet B. McGill, MD; William Polonsky, PhD; Elena Toschi, MD; HowardWolpert, MD; David Price, MD;

for the DIAMOND Study Group

Descarga el artículo 

Publicaciones Similares

Evolocumab and Clinical Outcomes in Patients with Card. Disease

PorSadeno

Descargue el artículo completo ABSTRACT BACKGROUND Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels…

Evidencias de los nuevos tratamientos para el colesterol

PorSadeno

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor  evolocumab: a prespecified secondary analysis of the FOURIER trial LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular disease. How much one should or safely can lower this risk factor remains debated. We aimed to explore the relationship between progressively lower…

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

PorSadeno

Consulta aquí el artículo: Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

AACE/ACE Consensus Statement

PorSadeno

CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM – 2017 EXECUTIVE SUMMARY   Autores: Alan J. Garber, MD, PhD, FACE1; Martin J. Abrahamson, MD2; Joshua I. Barzilay, MD, FACE3; Lawrence Blonde, MD, FACP, FACE4; Zachary T. Bloomgarden, MD, MACE5; Michael A. Bush, MD6; Samuel…

Rueda por la Diabetes al Mont Blanc, con el Doctor Delgado

PorSadeno

  El Doctor Elías Delgado, coordinador de Diabetes del Servicio de Endocrino del HUCA, participó el pasado mes de septiembre en el programa ‘Rueda por la Diabetes al Mont Blanc’, una ruta en bicicleta de montaña con personas con Diabetes Mellitus Tipo 1. El Doctor Delgado cuenta su experiencia en este post: El Tour del…